How Drug-Eluting Stents Are Revolutionizing Heart Disease Treatment in India

Coronary Artery Disease (CAD), a prevalent heart condition in India, is caused by fatty deposits narrowing the arteries. Angioplasty with Drug-Eluting Stents (DES), which help restore blood flow and manage heart health symptoms, is a common treatment. Over 1.5 million such heart health procedures are performed annually in the country.

Drug-Eluting Stents are small, mesh-like devices inserted during angioplasty to open blocked coronary arteries. Unlike older stents, they release medication directly at the treatment site, reducing the risk of re-narrowing and supporting long-term heart health.

Patients with CAD often experience chest pain, breathlessness, or even heart attacks if the condition goes untreated. Early diagnosis and prompt treatment are essential to prevent severe heart health complications. Angioplasty with DES typically leads to faster symptom relief and shorter hospital stays, provided patients follow prescribed medications and lifestyle changes.

These stents are suitable for a wide range of cases, including those with diabetes, multiple blockages, or complex artery structures. However, a stent alone is not enough—long-term heart health requires regular medication, a balanced diet, physical activity, and managing risk factors like high blood pressure or cholesterol.

While exact figures for 2023 are unavailable, industry reports indicate that drug-eluting stents are used in over 90% of angioplasty procedures in India. Understanding treatment options allows patients to take an active role in their heart health recovery. Proper follow-up care remains critical to maintaining heart health after the procedure.